[March 18, 2014] |
 |
Research and Markets: Research Report: South Korea Orthobiologics Market Outlook to 2020
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/wtxjbr/south_korea)
has announced the addition of the "South
Korea Orthobiologics Market Outlook to 2020" report to their
offering.
"South Korea Orthobiologics Market Outlook to 2020", provides key market
data on the South Korea Orthobiologics market. The report provides
value, in millions of US dollars, and volume (in units) and average
price data (in US dollars), within market categories - Bone Graft
Substitutes, Viscosupplementation, Bone Allografts and Bone Growth
Stimulators.
The report also provides company shares and distribution shares data for
each of these market categories, and global corporate-level profiles of
the key market participants, pipeline products, and news and deals
related to the Orthobiologics market wherever available.
The data in the report is derived from dynamic market forecast models.
The authors use epidemiology and capital equipment-based models to
estimate and forecast the market size. The objective is to provide
information that represents the most up-to-date data of the industry
possible.
The epidemiology-based forecasting model makes useof epidemiology data
gathered from research publications and primary interviews with
physicians to establish the target patient population and treatment flow
patterns for individual diseases and therapies. Using prevalence and
incidence data and diagnosed and treated population, the
epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the
installed base, replacements and new sales of a specific
device/equipment in healthcare facilities such as hospitals, clinics and
diagnostic centers. Data for average number of units per facility is
used to arrive at the installed base of the capital equipment. Sales for
a particular year are arrived at by calculating the replacement units
and new units (additional and first-time purchases).
Extensive interviews are conducted with key opinion leaders (KOLs),
physicians and industry experts to validate the market size, company
share and distribution share data and analysis.
Scope
- Market size for Orthobiologics market categories - Bone Graft
Substitutes, Viscosupplementation, Bone Allografts and Bone Growth
Stimulators.
- Annualized market revenues (USD million), volume (units) and average
selling price ($) data for each of the market categories. Data is
provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for each of the
market categories.
- Global corporate-level profiles of key companies operating within the
South Korea Orthobiologics market.
Key Topics Covered:
List of Tables
List of Figures
Introduction
Orthobiologics Market, South Korea
Overview of Key Companies in South Korea Orthobiologics Market
Orthobiologics Market Pipeline Products
Financial Deals Landscape
Recent Developments
Appendix
Companies Mentioned
Korea Bone Bank Inc.
DePuy Companies
Sanofi
Stryker Corporation
Biomet, Inc.
Medtronic, Inc.
For more information visit http://www.researchandmarkets.com/research/wtxjbr/south_korea
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.

[ Back To TMCnet.com's Homepage ]
|